arrow
M

Mario de Angelis

ieo european institute of oncology
H指数:17
被引数:1,332

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Comparisons of Novel Risk Stratification Models to the Current cT1a/b Staging in Incidental Prostate Cancer

对偶然性前列腺癌中新型风险分层模型与当前cT1a/b分期的比较

2026-09-290
PRE
ASO Visual Abstract: Cancer-Specific Mortality in Rare Histologic Subtypes of Prostate Cancer: Radical Prostatectomy Versus Radiation Therapy

ASO可视化摘要:前列腺癌罕见组织学亚型的癌症特异性死亡率:根治性前列腺切除术与放射治疗的比较

2026-09-070
PRE
Safety and feasibility of telesurgical robot assisted radical prostatectomy: prospective pilot study

远程手术机器人辅助根治性前列腺切除术的安全性与可行性:前瞻性试点研究

2026-09-010
PRE
Feasibility and safety of Toumai® robot-assisted radical prostatectomy: initial experience from a European referral centre

Toumai®机器人辅助根治性前列腺切除术的可行性与安全性:欧洲转诊中心的初步经验

2026-05-150
PRE
Clinical and surgical management of recto-urinary fistula after radical prostatectomy: a systematic review on current evidence

根治性前列腺切除术后直肠尿道瘘的临床与手术治疗:基于当前证据的系统评价

2026-05-020
PRE
The impact of age in patients with non-muscle-invasive bladder cancer treated with Bacillus Calmette-Guerin

非肌肉浸润性膀胱癌患者接受卡介苗治疗后年龄的影响

2026-05-010
PRE
Intraoperative margin assessment using fluorescence confocal microscopy during robot-assisted radical prostatectomy: a first experience

术中荧光共聚焦显微镜在机器人辅助根治性前列腺切除术中的切缘评估:初步经验

2026-03-010
OAAI
Cancer-Specific Mortality in Rare Histological Subtypes of Prostate Cancer: Radical Prostatectomy Versus Radiation Therapy

前列腺癌罕见组织学亚型的癌症特异性死亡率:根治性前列腺切除术与放射治疗的比较

2026-02-200
OAAI
Does Laterality Affect the Risk of Intraoperative Complications in Adrenalectomy?

肾上腺切除术的手术体位是否影响术中并发症风险?

2026-02-010
PRE
Impact of timing between neoadjuvant therapy and radical cystectomy on survival in muscle-invasive bladder cancer

新辅助治疗与根治性膀胱切除术时间间隔对肌层浸润性膀胱癌预后的影响

2025-11-080
PRE
Rates of Secondary Bladder and Rectal Cancers After External Beam Radiation for Prostate Cancer According to Age and D'amico Risk Groups in A Contemporary Cohort

根据年龄和D'amico风险组,当代队列中前列腺癌外照射放疗后继发性膀胱和直肠癌的发生率

2025-11-012
PRE
Sarcomatoid dedifferentiation as a predictor of overall mortality in surgically treated metastatic renal cell carcinoma
2025-11-010
PRE
Management and recurrence patterns of radiation-induced cystitis with hematuria: a persistent clinical challenge

放射性膀胱炎伴血尿的管理与复发模式:一个持续的临床挑战

2025-11-010
PRE
Cancer-specific mortality in secondary bladder cancer after nephroureterectomy for upper tract urothelial carcinoma
2025-11-010
OAAI
Real-world impact of cisplatin-based neoadjuvant chemotherapy on bladder cancer survival: a 20-year study

顺铂为基础的新辅助化疗对膀胱癌生存率的实际影响:一项20年研究

2025-10-280
PRE
Temporal trends and clinical determinants of urinary diversion after radical cystectomy

根治性膀胱切除术后尿流改道的时间趋势和临床决定因素

2025-10-010
PRE
Perioperative Radiotherapy and Survival After Surgical Treatment of Nonmetastatic Retroperitoneal Sarcoma

围手术期放疗及非转移性腹膜后肉瘤外科治疗后的生存情况

2025-10-010
PRE
Evolution of Perioperative Outcomes in Robot-Assisted Radical Cystectomy over 20 Years of Experience in a High-Volume Tertiary Robotic Center

机器人辅助根治性膀胱切除术围手术期结果的演变:一家高容量三级机器人中心的20年经验

2025-09-230
OAAI
Defining statistical cure in patients with T1 high-grade non-muscle-invasive bladder carcinoma treated with BCG immunotherapy

定义接受BCG免疫疗法治疗的T1高分级非肌层浸润性膀胱癌患者的统计学治愈

2025-08-290
PRE